Sera Prognostics (SERA) EBIT Margin Growth (3y) (2023 - 2026)

Sera Prognostics (SERA) EBIT Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -343.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 17.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -178.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -283.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,016.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 1,505.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -184.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -3,846.00
10 Sera Prognostics 93.48 Mn 93.48 Mn -28,000.00 -5.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.55 Mn
Dec 31, 2025 -7.35 Mn
Sep 30, 2025 -4.33 Mn
Jun 30, 2025 -3.98 Mn
Mar 31, 2025 802,632.00
Dec 31, 2024 899,519.00
Sep 30, 2024 1.05 Mn
Jun 30, 2024 -164,917.00
Dec 31, 2023 5.77 Mn
Sep 30, 2023 7.34 Mn
Jun 30, 2023 6.20 Mn